Mohamed Adil A. A
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mohamed Adil A. A has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Mohammad Waseem
B. S. Abdur Rahman Crescent Institute of Science and Technology, India
2 shared publicationsNeesar Ahmed
B. S. Abdur Rahman Crescent Institute of Science and Technology, India
2 shared publications- Neesar Ahmed
School of Life Sciences, B. S. Abdur Rahman Crescent Institute of Science & Technology, Vandalur, Chennai, India
2 shared publications Shazia Jamal
School of Life Sciences, B S Abdur Rahman Crescent Institute of Science and Technology, GST Road, Vandalur, Chennai, Tamil Nadu 600048 India
2 shared publications- Abdullah F. Alasmari
Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
1 shared publication Anandraj K. Vaithy.K
Mahatma Gandhi Medical College and Research Institute, India
1 shared publication
Latest Publications
- 1 January 2021
- Published by IGI Global Scientific Publishing
- p. 24-37
Protagonist of Immuno-Profiling, Immuno-Scoring, and Immunotherapy Towards Colitis-Associated Cancer
Chronic inflammation in the large intestinal epithelial to rectum is a major risk for malignancies. The pathogenesis of colitis associated cancer is distinct with perilous molecular mechanism. The inflammation leads to damage of cells resulting in symptomatic conditions including cancer. This suggest the relationship between certain cancer due to its associated factors such as environment, genetics, and chronic inflammation leading to cancer. Colorectal cancer (CRC) has also been acknowledged as bowel, rectal, or colon cancer. The most common types of adenocarcinomas are associated with colorectal cancer. The lymphomas, carcinoids, sarcoma, and gastrointestinal tumors are also associated with CRC. Most disorders with chronic inflammation and exposure of immunosuppressant have an increased risk with the development of cancer leading towards the treatment of cancer by various therapies like radiation therapy, chemotherapy, hormonal therapy, further into immunotherapy, and targeted therapy. The prognosis of CRC has always been controversial.
- 1 January 2021
- Published by IGI Global Scientific Publishing
- p. 24-37
Protagonist of Immuno-Profiling, Immuno-Scoring, and Immunotherapy Towards Colitis-Associated Cancer
Chronic inflammation in the large intestinal epithelial to rectum is a major risk for malignancies. The pathogenesis of colitis associated cancer is distinct with perilous molecular mechanism. The inflammation leads to damage of cells resulting in symptomatic conditions including cancer. This suggest the relationship between certain cancer due to its associated factors such as environment, genetics, and chronic inflammation leading to cancer. Colorectal cancer (CRC) has also been acknowledged as bowel, rectal, or colon cancer. The most common types of adenocarcinomas are associated with colorectal cancer. The lymphomas, carcinoids, sarcoma, and gastrointestinal tumors are also associated with CRC. Most disorders with chronic inflammation and exposure of immunosuppressant have an increased risk with the development of cancer leading towards the treatment of cancer by various therapies like radiation therapy, chemotherapy, hormonal therapy, further into immunotherapy, and targeted therapy. The prognosis of CRC has always been controversial.
- 18 March 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 26 (4) , 485-491
Emerging Role of Mitophagy in Inflammatory Diseases: Cellular and Molecular Episodes
Mitochondria are the crucial regulators for major source of ATP for different cellular events. Due to damage episodes, mitochondria have been established for plethora of an alarming signals of stress that leads to cellular deterioration and thereby causing programmed cell death. Defects in mitochondria plays a key role in arbitrating pathophysiological machinery with recent evince delineating a constructive role in mitophagy mediated mitochondrial injury. Mitophagy have been known for eradication of damaged mitochondria via autophagy process. Mitophagy has been investigated as an evolutionarily conserved mechanism for mitochondrial quality control and homeostasis. Impaired mitophagy has been critically linked with pathogenesis of inflammatory diseases. Nevertheless, the exact mechanism is not quite revealed, and it is still debatable. The purpose of this review was to enquire the possible role of mitophagy and its associated mechanism in inflammation mediated diseases at both cellular and molecular level.
- 18 March 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 26 (4) , 485-491
Emerging Role of Mitophagy in Inflammatory Diseases: Cellular and Molecular Episodes
Mitochondria are the crucial regulators for major source of ATP for different cellular events. Due to damage episodes, mitochondria have been established for plethora of an alarming signals of stress that leads to cellular deterioration and thereby causing programmed cell death. Defects in mitochondria plays a key role in arbitrating pathophysiological machinery with recent evince delineating a constructive role in mitophagy mediated mitochondrial injury. Mitophagy have been known for eradication of damaged mitochondria via autophagy process. Mitophagy has been investigated as an evolutionarily conserved mechanism for mitochondrial quality control and homeostasis. Impaired mitophagy has been critically linked with pathogenesis of inflammatory diseases. Nevertheless, the exact mechanism is not quite revealed, and it is still debatable. The purpose of this review was to enquire the possible role of mitophagy and its associated mechanism in inflammation mediated diseases at both cellular and molecular level.
- 16 April 2019
- Published by Springer Nature in 3 Biotech
- Vol. 9 (5) , 1-10
Differential expression of Helios, Neuropilin-1 and FoxP3 in head and neck squamous cell carcinoma (HNSCC) patients
In recent years, studies have begun to explore the immune involvement in head and neck tumors. Advanced stage head and neck squamous cell carcinoma (HNSCC) has a poor prognosis with low survival rates with high level of immune infiltrates. Tregs (regulatory T cells) play a crucial role in constructing an immunosuppressive tumor microenvironment. In the present study, we highlighted specific Treg markers and its factors in HNSCC solid tumors and peripheral blood of cancer patients. By histopathology and immunofluorescence staining, we observed differential expression of CD4, CD25, Foxp3, Helios and Neuropilin-1. Further, we analyzed the expression of Foxp3, Helios, Neuropilin-1 and GARP by qPCR and flow cytometry in whole blood and found to be elevated in HNSCC patients in comparison with healthy donors. Additionally, IFN-γ, TGF-β, IL-6, IL-2, IL-10 and TNF-α expressions were also found to be relatively increased in the head and neck cancer patients when compared with healthy donors. Our findings emphasize that Tregs may be involved in promoting tumor progression. Helios and Neuropilin-1 could be potent markers in identifying subsets of Tregs. Association of soluble factors could sculpture the activity of Tregs. With further research, Treg markers and its associated soluble factors could be employed to block Tregs trafficking to the tumor, thus enlightening a potential strategy for targeting human cancers.
- 16 April 2019
- Published by Springer Nature in 3 Biotech
- Vol. 9 (5) , 1-10
Differential expression of Helios, Neuropilin-1 and FoxP3 in head and neck squamous cell carcinoma (HNSCC) patients
In recent years, studies have begun to explore the immune involvement in head and neck tumors. Advanced stage head and neck squamous cell carcinoma (HNSCC) has a poor prognosis with low survival rates with high level of immune infiltrates. Tregs (regulatory T cells) play a crucial role in constructing an immunosuppressive tumor microenvironment. In the present study, we highlighted specific Treg markers and its factors in HNSCC solid tumors and peripheral blood of cancer patients. By histopathology and immunofluorescence staining, we observed differential expression of CD4, CD25, Foxp3, Helios and Neuropilin-1. Further, we analyzed the expression of Foxp3, Helios, Neuropilin-1 and GARP by qPCR and flow cytometry in whole blood and found to be elevated in HNSCC patients in comparison with healthy donors. Additionally, IFN-γ, TGF-β, IL-6, IL-2, IL-10 and TNF-α expressions were also found to be relatively increased in the head and neck cancer patients when compared with healthy donors. Our findings emphasize that Tregs may be involved in promoting tumor progression. Helios and Neuropilin-1 could be potent markers in identifying subsets of Tregs. Association of soluble factors could sculpture the activity of Tregs. With further research, Treg markers and its associated soluble factors could be employed to block Tregs trafficking to the tumor, thus enlightening a potential strategy for targeting human cancers.
- 1 January 2019
- Published by Begell House Inc. Publishers in Journal of Environmental Pathology, Toxicology and Oncology
- Vol. 38 (2) , 173-183
Increased Expression of TGF-β and IFN-γ in Peripheral Blood Mononuclear Cells (PBMCs) Cultured in Conditioned Medium (CM) of K562 Cell Culture
In the present study we have investigated the effect of conditioned media (CM) collected from the cancer cell lines (K562, MCF-7, and HeLa) on Peripheral blood mononuclear cells (PBMCs) isolated from the healthy human blood. The soluble factors in the CM are probably responsible for the differential mRNA expression of Foxp3, Helios, Neuropilin-1 (NRP-1) and Glycoprotein A repetitions predominant (GARP) along with IFNγ and TGF-β in PBMCs cultured with cancer cells CM. The PBMCs cultured with CM of K562 showed increased expression of Foxp3, Helios, NRP-1, GARP, IFNγ and TGF-β compared to PBMCs cultured with MCF-7 and HeLa cells. In addition, the intracellular staining on PBMCs cultured with CM from cell lines were also evaluated for CD4, CD25, Foxp3, Helios and NRP-1 by multicolor flow cytometry. The expression of CD4+CD25+Foxp3+, CD4+Helios+Foxp3+ and CD+NRP-1+Foxp3+ showed retarded cell population as compared to control PBMCs. Our data suggest data suggest that soluble factors in CM of cancer cells may trigger the immune response in PBMCs resulting in a systematic response. Further research could enable to identify the specific soluble factors that are involved in trafficking of cells into the immune cascades, which might be a potentially safe and promising strategy for targeting human cancers.
- 1 January 2019
- Published by Begell House Inc. Publishers in Journal of Environmental Pathology, Toxicology and Oncology
- Vol. 38 (2) , 173-183
Increased Expression of TGF-β and IFN-γ in Peripheral Blood Mononuclear Cells (PBMCs) Cultured in Conditioned Medium (CM) of K562 Cell Culture
In the present study we have investigated the effect of conditioned media (CM) collected from the cancer cell lines (K562, MCF-7, and HeLa) on Peripheral blood mononuclear cells (PBMCs) isolated from the healthy human blood. The soluble factors in the CM are probably responsible for the differential mRNA expression of Foxp3, Helios, Neuropilin-1 (NRP-1) and Glycoprotein A repetitions predominant (GARP) along with IFNγ and TGF-β in PBMCs cultured with cancer cells CM. The PBMCs cultured with CM of K562 showed increased expression of Foxp3, Helios, NRP-1, GARP, IFNγ and TGF-β compared to PBMCs cultured with MCF-7 and HeLa cells. In addition, the intracellular staining on PBMCs cultured with CM from cell lines were also evaluated for CD4, CD25, Foxp3, Helios and NRP-1 by multicolor flow cytometry. The expression of CD4+CD25+Foxp3+, CD4+Helios+Foxp3+ and CD+NRP-1+Foxp3+ showed retarded cell population as compared to control PBMCs. Our data suggest data suggest that soluble factors in CM of cancer cells may trigger the immune response in PBMCs resulting in a systematic response. Further research could enable to identify the specific soluble factors that are involved in trafficking of cells into the immune cascades, which might be a potentially safe and promising strategy for targeting human cancers.
- Open Access
- 1 January 2014
- Published by HATASO Enterprises LLC in Oncobiology and Targets
- Vol. 1 (1) , 16
Cancer immunotherapy: Targeting immunosuppressive tumor microenvironment
- 1 January 2014
- Published by HATASO Enterprises LLC in Oncobiology and Targets
- Vol. 1 (1) , 16
Open AccessCancer immunotherapy: Targeting immunosuppressive tumor microenvironment